You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH):擬認購聯合健康險新增發行股份
格隆匯 03-31 19:40

格隆匯3月31日丨復星醫藥(600196.SH)公佈,公司、國際金融公司(IFC)、亞洲開發銀行(ADB)與聯合健康險共同簽訂《股份認購協議》,本公司與國際金融公司(IFC)、亞洲開發銀行(ADB)擬各自出資人民幣27,000萬元(或等值美元)分別認購聯合健康險105,468,750股新增發行股份(對應新增註冊資本人民幣105,468,750元);同日,包括本公司在內的本次增資投資方與聯合健康險及其相關現有股東共同簽訂《股東協議》,並與聯合健康險、復星產投共同簽訂《隨售權協議》。本次增資對應標的公司的投前估值系基於上海東洲資產評估有限公司出具之《資產評估報告》所載的截至2024年12月31日聯合健康險的股東全部權益評估價值(採用市場法評估結果作爲評估結論),經相關各方協商確定。

本公司擬以自有資金支付本次增資的對價。本次增資完成後,本公司持有聯合健康險的股權比例將由14.00%增至20.05%。由於本公司董事兼任標的公司的董事,且標的公司現有股東之一的復星產投與本公司的控股股東同爲復星高科技,根據上證所《上市規則》,聯合健康險構成本公司的關聯方、本次增資構成本公司的關聯交易。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account